| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8653005 | The Annals of Thoracic Surgery | 2017 | 6 Pages |
Abstract
EPO attenuates neuronal loss after oxygen-glucose deprivation in a βcR-dependent fashion. This receptor holds immense clinical promise as a target for pharmacotherapies treating spinal cord ischemic injury.
Related Topics
Health Sciences
Medicine and Dentistry
Cardiology and Cardiovascular Medicine
Authors
Lisa S. MD, David A. MD, Joshua BA, Mitchell BA, Michael J. MD, Joseph C. MD, T. Brett MD,